| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 5.4% | $14,069,150 | 2,819,469 | The Vanguard Group | 31 Mar 2025 | |||
| GOLDMAN SACHS GROUP INC | 0% | $1,531 | 308 | THE GOLDMAN SACHS GROUP, INC. | 30 Jun 2025 |
As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT). This represents 0% of the company’s total 52,406,487 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$507,987 | $5.00 | 0 |
| 2025 Q2 | 95,972 | $507,987 | -$233,368,571 | $9.92 | 2 |
| 2025 Q1 | 47,343,776 | $233,886,428 | +$26,350,036 | $4.94 | 135 |
| 2024 Q4 | 45,953,282 | $135,099,391 | -$4,233,897 | $2.94 | 115 |
| 2024 Q3 | 45,014,292 | $212,478,861 | -$12,126,215 | $4.72 | 112 |
| 2024 Q2 | 47,616,396 | $183,350,210 | +$592,537 | $3.85 | 112 |
| 2024 Q1 | 46,621,664 | $249,450,311 | -$4,585,028 | $5.35 | 112 |
| 2023 Q4 | 48,194,986 | $205,771,368 | -$19,985,874 | $4.27 | 113 |
| 2023 Q3 | 54,800,462 | $214,765,730 | -$17,309,644 | $3.92 | 140 |
| 2023 Q2 | 49,877,027 | $504,757,759 | +$349,413 | $10.12 | 145 |
| 2023 Q1 | 49,797,308 | $508,015,188 | +$174,343,587 | $10.20 | 140 |
| 2022 Q4 | 32,832,112 | $307,624,848 | -$28,979,577 | $9.37 | 132 |
| 2022 Q3 | 33,935,762 | $493,769,986 | -$11,534,913 | $14.55 | 113 |
| 2022 Q2 | 34,631,078 | $457,133,912 | +$34,811,430 | $13.20 | 115 |
| 2022 Q1 | 31,860,508 | $543,474,449 | +$220,494,653 | $17.06 | 116 |
| 2021 Q4 | 18,695,153 | $479,312,107 | +$479,312,107 | $25.63 | 108 |